Search results
Bad for the Brain, Bad for the Planet
Medscape· 4 days agoDrs Indu Subramanian and Ali Saad discuss how diet, air pollution, and heat affect neurologic conditions and why neurologists shouldn't ignore climate...
People with type 1 diabetes are living longer - UPI.com
UPI· 2 days agoPeople with type 1 diabetes are 25% less likely to die early now than they were in 1990, a new ...
New position paper addresses optimization of vitamin D status in global populations
Medical Xpress· 4 days agoA position paper authored on behalf of the International Osteoporosis Foundation (IOF) Vitamin D...
Springbok Analytics Announces Phase 1 Clinical Trial Evaluating Clenbuterol as FSHD Treatment
The Tomahawk· 3 days agoSpringbok Analytics (www.springbokanalytics.com), a life sciences muscle analytics company, announced today its participation in a Phase 1 Clinical Trial to evaluate safe dosage for clenbuterol ...
'Dramatic' Phase 2 Results for Survodutide in MASH, Fibrosis
Medscape· 3 days agoSurvodutide, a dual agonist that targets glucagon and glucagon-like peptide 1 receptors, led to a...
People Are Living Longer With Type 1 Diabetes | FOX 28 Spokane
FOX 28 Spokane· 2 days agoPeople with type 1 diabetes are 25% less likely to die early now than they were in 1990, a new ...
The Shifting Epidemiology of Hypercholesterolemia
MedPage Today· 2 days agoThe epidemiology of hypercholesterolemia has been shifting in recent years. The optimal total cholesterol level is defined as about 150 mg/dL, putting low-density lipoprotein ...
Alarming trends call for action to define the future role of food in nation s health
NewMediaWire via Yahoo Finance· 5 days agoCHICAGO, June 10, 2024 — The cost of nutritious food and the lack of access to it are of significant...
How to Safely Discontinue Multiple Myeloma Maintenance Care
Medscape· 1 day agoNew research suggested that the key to safely discontinuing multiple myeloma maintenance therapy is...
Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity
NBC 17 Raleigh· 3 days agoPalatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin ...
